The Need for a Revised Approach to Epidemiological Monitoring of the Prevalence of Visual Impairment

Click to increase image sizeClick to decrease image size

ACKNOWLEDGMENTS

a. Funding/Support (including none): Dr. Kempen receives research support from the National Eye Institute Grant R01 EY014943, National Eye Institute Grant U10 EY014655, Research to Prevent Blindness, and the Paul and Evanina Mackall Foundation. None of the sponsors had any role in the preparation, review, and approval of this manuscript.

b. Financial Disclosures: John H. Kempen: (Consultant, C) Lux Biosciences, (C) Alcon, (C) Allergan, (C) Sanofi Pasteur.

c. Contributions of Authors: Writing the Article (JHK); Critical Review of the Article (JHK); Final Approval of the Article (JHK)

d. Statement about Conformity with Author Information: This editorial does not constitute original research utilizing human or animal subjects and therefore approval or exemption Institutional Review Board and Institutional Animal Care and Use and HIPAA compliance are not applicable.

e. Other Acknowledgments: None